Combinostics uses AI to improve early diagnosis

New Finnish technology is tapping into machine learning and artificial intelligence to support healthcare professionals in early diagnosis of neurological disorders. When a person is suspected of having a memory disorder, they undergo extensive tests ranging from brain scans to neurological examinations. It is then up to their physician to analyse the results. However, even an experienced doctor may struggle to arrive at an accurate diagnosis during the early stages of a disease. Finnish healthtech company Combinostics has a solution for this in mind: its cloud-based tools for the comprehensive analysis of patient data.